Smart Strategies for Savings Presented at ASHP MeetingPharmacy Practice NewsThe cost for inpatient rituximab (Rituxan, Genentech) alone decreased from baseline by more than $250,000 in FY10 and by $150,000 in FY11. The driving force behind the savings …
Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab …7thSpace Interactive (press release)In clinical and experimental settings, antibody-based anti-CD20/rituximab and small molecule proteasome inhibitor (PI) bortezomib (BTZ) trea…
T-Cell/Histiocyte-Rich Large B-Cell Lymphoma of the Thyroid7thSpace Interactive (press release)She promptly underwent surgery with resection of the thyroid tumor, and the diagnosis of THRLBCL was established pathologically. She was successfully treated…
A possible coincidence of cytomegalovirus retinitis and intraocular lymphoma …7thSpace Interactive (press release)She experienced a relapse 19 months later with involvement of the retroperitoneal lymph nodes, and commenced treatment with rituximab an…
Abatacept effectively, safely treated RA patients who failed anti-TNF …HealioAbatacept was safe and effective therapy for patients with severe rheumatoid arthritis who had failed to respond to anti-tumor necrosis factor therapy and rituximab in a rec…
Drug combination acts against aggressive chronic lymphocytic leukemiaOncology Nurse AdvisorThis phase II study enrolled 40 patients with high-risk CLL, who received daily oral doses of 420 mg ibrutinib throughout treatment, weekly infusions of 375 mg/m…
Rituxan Add-On Curbs RA Joint DamageMedPage TodayAdding the B-cell depleting agent rituximab (Rituxan) to methotrexate slowed joint damage progression in patients with rheumatoid arthritis (RA) regardless of the level of disease activity, Austrian rese…
Ibrutinib appears safe, effective against chronic lymphocytic leukemiaOncology Nurse AdvisorAs explained in an ASH statement, primary treatment for CLL includes a combined chemotherapy-based regimen with fludarabine and cyclophosphamide, along with the…
Researchers identify rituximab-insensitive cells in patients with refractory …Science CodexPrimary immune thrombocytopenia purpura (ITP) is a bleeding disorder in which the immune system generates antibodies that destroy platelets, the cells that cau…
 Medscape |
Management of Rheumatologic Diseases in Pregnancy
Medscape Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood117,1499–1506 (2011). Fischer-Betz R, Specker C, Schneider M. Successful outcome of two pregnancies in patients with adult-onset Still’s … |